Inactive Instrument

Insiders Oramed Pharmaceuticals, Inc. Xetra

Equities

OJU

US68403P1049

End-of-day quote Xetra Other stock markets
- ^EUR	-

06-12	Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket	MT
06-10	Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024	06-10	CI
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Treasurer and Secretary, Effective as of June 18, 2024	06-10	CI
Compugen Names David Silberman CFO	05-15	MT
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024	05-13	CI
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	03-19	CI
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	01-19	CI
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	12-19	CI
Oramed Pharmaceuticals Inc. Appoints Ben Shapiro to Its Board of Directors	01/05/23	CI
Insider Buy: Oramed Pharmaceuticals	15/03/23	MT
Insider Sell: Oramed Pharmaceuticals	04/01/23	MT
Oramed Pharmaceuticals Inc. Appoints Anne Peters to Its Scientific Advisory Board	01/06/22	CI
Oramed Pharmaceuticals Inc Announces Appoints Yadin Rozov to Its Board of Directors	04/04/22	CI
Oramed Pharmaceuticals Inc. Announces the Appointment of Netanel Derovan as Chief Legal Officer (General Counsel) and Company Secretary, Effective January 9, 2022	08/12/21	CI
Insider Sell: Oramed Pharmaceuticals	20/09/21	MT
Oramed Pharmaceuticals Inc. Appoints Michael Rabinowitz as Chief Commercial Officer	29/07/21	CI
Oramed Pharmaceuticals Inc. Appoints David Silberman as Treasurer and Secretary, Effective July 5, 2021	25/05/21	CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Treasurer and Secretary Effective July 5, 2021	10/05/21	CI
Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Chief Financial Officer, Effective July 5, 2021	10/05/21	CI
Oramed Appoints Dr. Julio Rosenstock to its Scientific Advisory Board	30/01/20	CI
Oramed Pharmaceuticals Inc. Elects Alexander Fleming to Scientific Advisory Board	23/01/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Oramed Pharmaceuticals, Inc. Xetra

Equities

OJU

US68403P1049

Insiders

Filters